---
figid: PMC6996551__CMAR-12-675-g0001
figlink: pmc/articles/PMC6996551/figure/F0001/
number: F1
caption: 'The role of cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC. ER transcriptional
  activity and signaling through HER2/PI3K/AKT/mTOR increase cyclin D1 levels, activating
  CDK4/6 and promoting cellular progression to the S phase. Combined inhibition of
  CDK4/6 and nodes in the PI3K pathway can suppress mTORC1 activity as well as RB
  phosphorylation, inhibiting two promoters of S phase progression.Abbreviations:
  EGFR, epidermal growth factor receptor; ER, estrogen receptor; HER, human epidermal
  growth factor receptor; mTOR, mammalian target of rapamycin; PI3K, phosphoinositide-3-kinase;
  RB, retinoblastoma protein; TSC2, tuberous sclerosis complex 2.'
pmcid: PMC6996551
papertitle: 'Strategies for Increasing the Effectiveness of Aromatase Inhibitors in
  Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options.'
reftext: Giulia Grizzi, et al. Cancer Manag Res. 2020;12:675-686.
pmc_ranked_result_index: '32030'
pathway_score: 0.8957155
filename: CMAR-12-675-g0001.jpg
figtitle: Cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC
year: '2020'
organisms:
- Mouse mammary tumor virus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6996551__CMAR-12-675-g0001.html
  '@type': Dataset
  description: 'The role of cyclin D1–CDK4/6–RB and PI3K/AKT/mTOR pathways in BC.
    ER transcriptional activity and signaling through HER2/PI3K/AKT/mTOR increase
    cyclin D1 levels, activating CDK4/6 and promoting cellular progression to the
    S phase. Combined inhibition of CDK4/6 and nodes in the PI3K pathway can suppress
    mTORC1 activity as well as RB phosphorylation, inhibiting two promoters of S phase
    progression.Abbreviations: EGFR, epidermal growth factor receptor; ER, estrogen
    receptor; HER, human epidermal growth factor receptor; mTOR, mammalian target
    of rapamycin; PI3K, phosphoinositide-3-kinase; RB, retinoblastoma protein; TSC2,
    tuberous sclerosis complex 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB3
  - ERBB2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - TSC2
  - MTOR
  - CDK4
  - CDK6
  - E2F3
  - E2F8
  - E2F1
  - E2F2
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - lapatinib
  - neratinib
  - letrozole
  - anastrozole
  - exemestane
  - Estradiol
  - buparlisib
  - tamoxifen
  - everolimus
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK4/6inhibitors
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
chemicals:
- word: lapatinib
  source: MESH
  identifier: C490728
- word: neratinib
  source: MESH
  identifier: C487932
- word: letrozole
  source: MESH
  identifier: C067431
- word: anastrozole
  source: MESH
  identifier: C090450
- word: exemestane
  source: MESH
  identifier: C056516
- word: Estradiol
  source: MESH
  identifier: D004958
- word: buparlisib
  source: MESH
  identifier: C571178
- word: tamoxifen
  source: MESH
  identifier: D013629
- word: everolimus
  source: MESH
  identifier: C107135
diseases: []
figid_alias: PMC6996551__F1
redirect_from: /figures/PMC6996551__F1
figtype: Figure
---
